Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 7, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • New Research Reveals Androgen Receptor promotes Cancer

NIPGR Research Associate Recruitment | MTech & Ph.D. Apply Online

Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US

New Research Reveals Androgen Receptor promotes Cancer
  • BiotechToday
  • World

New Research Reveals Androgen Receptor promotes Cancer

bioxone March 3, 2021March 3, 2021

Thota Kanishka Rao, Amity University Kolkata

Prostate cancer growth (PCa) is the most common disease after skin disease and the subsequent driving reason for cancer death in men. Androgen receptor (AR) flagging is fundamental for PCa cell development and endurance. Hence, androgen development treatment (ADT) is the standard treatment for advanced/metastatic PCa. 

Notwithstanding, patients unavoidably develop deadly castration-resistant PCa (CRPC), including protection from the most exceptional treatments: enzalutamide, apalutamide, and abiraterone. Most CRPCs express initiated AR and attacking AR signaling enactment stays a significant therapeutic path for CRPC. 

GATA2 is a transcription factor and pioneer factor critical for instigating AR articulation and initiation in PCa. GATA2 protein expression in human PCa tissues corresponds with advanced stages and worse prognosis. GATA2 protein is unstable and the molecular workings that control GATA2 security in PCa stay obscure. 

AKT assumes pivotal parts in managing cell endurance, multiplication, and digestion. In the standard PI3K/AKT/mTOR pathway, PI3K catalyzes PIP3 creation to enroll AKT to the cell membrane for activation.  The 2 mTOR complexes, mTORC2 and mTORC1, act by AKT. mTORC2 is a significant AKT S473 kinase, which cooperates with PDK1, an AKT T308 kinase, to completely enact AKT.  Interestingly, mTORC1 is enacted by AKT and is an indispensable center point that incorporates extracellular and nutrient signs to adjust cell development, autophagy, and digestion.

PTEN, alongside PHLPP phosphatases and INPP4B, offer a significant brake to control the PI3K/AKT pathway. Atypical initiation of the PI3K/AKT/mTOR signaling prompts numerous obsessive results, including tumors. Complex complementary crosstalk between the PI3K/AKT/mTOR and AR pathways at numerous levels has been accounted for. The focal subject is commonly opposing exercises of PI3K/AKT/mTOR and AR, albeit different cooperations have likewise been accounted for.

Also read: March: Colorectal cancer awareness month

Source: J Clin Invest. 2021;131(4):e141335. https://doi.org/10.1172/JCI141335.

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged abiraterone ADT AKT androgen development treatment androgen receptor apalutamide AR Autophagy cancer CRPC enzalutamide INPP4B mTOR complex mTORC1 mTORC2 PDK1 PHLPP phosphatases PI3K PI3K/AKT/mTOR pathway prostate cancer prostate cancer growth PTEN T308 kinase

One thought on “New Research Reveals Androgen Receptor promotes Cancer”

  1. Pingback: Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US

bioxone March 4, 2021

Devyani Goswami, Amity University Kolkata Nanette Cocero, global president, vaccines, of Pfizer announced that their tick-borne encephalitis vaccine (TBE) has been approved for a priority review from the US Food and Drug Administration (FDA).  Once approved the vaccine promises to cure tick-borne encephalitis epidemics all across the US. The vaccine has to be subjected twice […]

tick-borne encephalitis

Related Post

  • BiotechToday
  • World

HELLO- A method based on DNN architecture

bioxone August 18, 2021August 18, 2021

Madhavi Bhatia, National Pharmaceutical Education and Research, Guwahati Variant calling is the process by which we can identify variants in the sequence data provided. Variant calling has a major application in modern bioinformatics. It helps in discovering the underlying traits of Mendelian diseases, in understanding the individual’s susceptibility to cancer, and also to study genetic […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India
  • World

Can mutation make you lose your sense of smell?

bioxone October 10, 2020October 10, 2020

-Husna, Amity University Kolkata The loss in sense of smell and taste experienced most commonly due to viral fever is termed as Anosmia. Millions of olfactory receptor cells are present in our nasal cavity. These cells captures molecules with specific odour and activate a nerve response which then carries the signal to the brain where […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Understanding the potential of the Coronavirus alpha variant

BioTech Today July 3, 2021July 3, 2021

Neha khan, Jamia Millia Islamia What is the alpha variant? The B.1.1.7 variant is known as the Alpha variant which was first found in India and had taken thousands of lives. This coronavirus variant is more infectious than other variants because it foils the innate immune system for a while till it replicates and finds […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy